Wird geladen...
Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
Breast cancer is one of the leading causes of death in women in the United States. In general, patients with breast cancer undergo surgical resection of the tumor and/or receive drug treatment to kill or suppress the growth of cancer cells. In this regard, small molecule kinase inhibitors serve as a...
Gespeichert in:
| Veröffentlicht in: | Cancer Drug Resist |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
OAE Publishing Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100881/ https://ncbi.nlm.nih.gov/pubmed/32226926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.100 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|